Skip to main content
Top
Published in: Medical Microbiology and Immunology 4/2012

01-11-2012 | Review

Viral latency drives ‘memory inflation’: a unifying hypothesis linking two hallmarks of cytomegalovirus infection

Authors: Christof K. Seckert, Marion Grießl, Julia K. Büttner, Sabine Scheller, Christian O. Simon, Kai A. Kropp, Angélique Renzaho, Birgit Kühnapfel, Natascha K. A. Grzimek, Matthias J. Reddehase

Published in: Medical Microbiology and Immunology | Issue 4/2012

Login to get access

Abstract

Low public awareness of cytomegalovirus (CMV) results from the only mild and transient symptoms that it causes in the healthy immunocompetent host, so that primary infection usually goes unnoticed. The virus is not cleared, however, but stays for the lifetime of the host in a non-infectious, replicatively dormant state known as ‘viral latency’. Medical interest in CMV results from the fact that latent virus can reactivate to cytopathogenic, tissue-destructive infection causing life-threatening end-organ disease in immunocompromised recipients of solid organ transplantation (SOT) or hematopoietic cell transplantation (HCT). It is becoming increasingly clear that CMV latency is not a static state in which the viral genome is silenced at all its genetic loci making the latent virus immunologically invisible, but rather is a dynamic state characterized by stochastic episodes of transient viral gene desilencing. This gene expression can lead to the presentation of antigenic peptides encoded by ‘antigenicity-determining transcripts expressed in latency (ADTELs)’ sensed by tissue-patrolling effector-memory CD8 T cells for immune surveillance of latency [In Reddehase et al., Murine model of cytomegalovirus latency and reactivation, Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 315–331, 2008]. A hallmark of the CD8 T cell response to CMV is the observation that with increasing time during latency, CD8 T cells specific for certain viral epitopes increase in numbers, a phenomenon that has gained much attention in recent years and is known under the catchphrase ‘memory inflation.’ Here, we provide a unifying hypothesis linking stochastic viral gene desilencing during latency to ‘memory inflation.’
Literature
1.
go back to reference Seo S, Boeckh M (2013) Clinical cytomegalovirus research: hematopoietic cell transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 16. Caister Academic Press, Norfolk, UK (in press) Seo S, Boeckh M (2013) Clinical cytomegalovirus research: hematopoietic cell transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 16. Caister Academic Press, Norfolk, UK (in press)
2.
go back to reference Avery RK (2013) Clinical cytomegalovirus research: thoracic organ transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 13. Caister Academic Press, Norfolk, UK (in press) Avery RK (2013) Clinical cytomegalovirus research: thoracic organ transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 13. Caister Academic Press, Norfolk, UK (in press)
3.
go back to reference Emery VC, Milne RS, Griffiths PD (2013) Clinical cytomegalovirus research: liver and kidney transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 14. Caister Academic Press, Norfolk, UK (in press) Emery VC, Milne RS, Griffiths PD (2013) Clinical cytomegalovirus research: liver and kidney transplantation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 14. Caister Academic Press, Norfolk, UK (in press)
4.
go back to reference Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 297–314 Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 297–314
5.
go back to reference Reeves M, Sinclair J (2013) Epigenetic regulation of human cytomegalovirus gene expression: impact on latency and reactivation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 19. Caister Academic Press, Norfolk, UK (in press) Reeves M, Sinclair J (2013) Epigenetic regulation of human cytomegalovirus gene expression: impact on latency and reactivation. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 19. Caister Academic Press, Norfolk, UK (in press)
6.
go back to reference Slobedman B, Avdic S, Abendroth A (2013) Transcription associated with human cytomegalovirus latency. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 20. Caister Academic Press, Norfolk, UK (in press) Slobedman B, Avdic S, Abendroth A (2013) Transcription associated with human cytomegalovirus latency. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 20. Caister Academic Press, Norfolk, UK (in press)
7.
go back to reference Smith MS, Streblow DN, Caposio P, Nelson JA (2013) Humanized mouse models of cytomegalovirus pathogenesis and latency. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 23. Caister Academic Press, Norfolk, UK (in press) Smith MS, Streblow DN, Caposio P, Nelson JA (2013) Humanized mouse models of cytomegalovirus pathogenesis and latency. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 23. Caister Academic Press, Norfolk, UK (in press)
8.
go back to reference *Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus: overview. J Clin Virol 25:S23–S36PubMedCrossRef *Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus: overview. J Clin Virol 25:S23–S36PubMedCrossRef
9.
go back to reference Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25:S123–S136PubMedCrossRef Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25:S123–S136PubMedCrossRef
10.
go back to reference *Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK (2008) Murine model of cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 315–331 *Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK (2008) Murine model of cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 315–331
11.
go back to reference *Seckert CK, Grießl M, Büttner JK, Freitag K, Lemmermann NA, Hummel MA, Liu XF, Abecassis MI, Angulo A, Messerle M, Cook CH, Reddehase MJ (2013) Immune surveillance of cytomegalovirus latency and reactivation in murine models: link to “memory inflation”. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 22. Caister Academic Press, Norfolk, UK (in press) *Seckert CK, Grießl M, Büttner JK, Freitag K, Lemmermann NA, Hummel MA, Liu XF, Abecassis MI, Angulo A, Messerle M, Cook CH, Reddehase MJ (2013) Immune surveillance of cytomegalovirus latency and reactivation in murine models: link to “memory inflation”. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 22. Caister Academic Press, Norfolk, UK (in press)
12.
go back to reference Emery VC (1998) Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) Monographs in virology 21: CMV-related immunopathology. Karger, Basel, pp 288–301 Emery VC (1998) Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) Monographs in virology 21: CMV-related immunopathology. Karger, Basel, pp 288–301
13.
go back to reference Davison AJ, Holton M, Dolan A, Dargan DJ, Gatherer D, Hayward GS (2013) Comparative genomics of primate cytomegaloviruses. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 1. Caister Academic Press, Norfolk, UK (in press) Davison AJ, Holton M, Dolan A, Dargan DJ, Gatherer D, Hayward GS (2013) Comparative genomics of primate cytomegaloviruses. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 1. Caister Academic Press, Norfolk, UK (in press)
14.
go back to reference Adler B, Sinzger C (2013) Cytomegalovirus inter-strain variance in cell-type tropism. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 17. Caister Academic Press, Norfolk, UK (in press) Adler B, Sinzger C (2013) Cytomegalovirus inter-strain variance in cell-type tropism. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 17. Caister Academic Press, Norfolk, UK (in press)
15.
go back to reference Mercer JA, Wiley CA, Spector DH (1988) Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infection. J Virol 62:987–997PubMed Mercer JA, Wiley CA, Spector DH (1988) Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infection. J Virol 62:987–997PubMed
16.
go back to reference Pomeroy C, Hilleren PJ, Jordan MC (1991) Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 65:3330–3334PubMed Pomeroy C, Hilleren PJ, Jordan MC (1991) Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 65:3330–3334PubMed
17.
go back to reference Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufmann DB, Fryer JP, Stuart FP, Abecassis MI (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72:95–103PubMed Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufmann DB, Fryer JP, Stuart FP, Abecassis MI (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72:95–103PubMed
18.
go back to reference Balthesen M, Messerle M, Reddehase MJ (1993) Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67:5360–5366PubMed Balthesen M, Messerle M, Reddehase MJ (1993) Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67:5360–5366PubMed
19.
go back to reference Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193PubMedCrossRef Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193PubMedCrossRef
20.
go back to reference Kurz SK, Rapp M, Steffens HP, Grzimek NKA, Schmalz S, Reddehase MJ (1999) Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73:482–494PubMed Kurz SK, Rapp M, Steffens HP, Grzimek NKA, Schmalz S, Reddehase MJ (1999) Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73:482–494PubMed
21.
go back to reference *Seckert CK, Renzaho A, Reddehase MJ, Grzimek NK (2008) Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol 197:251–259PubMedCrossRef *Seckert CK, Renzaho A, Reddehase MJ, Grzimek NK (2008) Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol 197:251–259PubMedCrossRef
22.
go back to reference Daley-Bauer LP, Mocarski ES (2013) Myeloid cell recruitment and function in cytomegalovirus immunity and pathogenesis. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 21. Caister Academic Press, Norfolk, UK (in press) Daley-Bauer LP, Mocarski ES (2013) Myeloid cell recruitment and function in cytomegalovirus immunity and pathogenesis. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 21. Caister Academic Press, Norfolk, UK (in press)
23.
go back to reference *Marquardt A, Halle S, Seckert CK, Lemmermann NA, Veres TZ, Braun A, Maus UA, Förster R, Reddehase MJ, Messerle M, Busche A (2011) Single cell detection of latent cytomegalovirus reactivation in host tissue. J Gen Virol 92:1279–1291PubMedCrossRef *Marquardt A, Halle S, Seckert CK, Lemmermann NA, Veres TZ, Braun A, Maus UA, Förster R, Reddehase MJ, Messerle M, Busche A (2011) Single cell detection of latent cytomegalovirus reactivation in host tissue. J Gen Virol 92:1279–1291PubMedCrossRef
24.
go back to reference *Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, Kühnapfel B, Reddehase MJ, Grzimek NKA (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83:8869–8884PubMedCrossRef *Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, Kühnapfel B, Reddehase MJ, Grzimek NKA (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83:8869–8884PubMedCrossRef
25.
go back to reference Roizman B, Sears AE (1987) An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 41:543–571PubMedCrossRef Roizman B, Sears AE (1987) An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 41:543–571PubMedCrossRef
26.
go back to reference *Sacher T, Podlech J, Mohr CA, Jordan S, Ruzsics Z, Reddehase MJ, Koszinowski UH (2008) The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3:263–272PubMedCrossRef *Sacher T, Podlech J, Mohr CA, Jordan S, Ruzsics Z, Reddehase MJ, Koszinowski UH (2008) The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3:263–272PubMedCrossRef
27.
go back to reference *Sacher T, Andrassy J, Kalnins A, Dölken L, Jordan S, Podlech J, Ruzsics Z, Jauch KW, Reddehase MJ, Koszinowski UH (2011) Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog 7:e1002366PubMedCrossRef *Sacher T, Andrassy J, Kalnins A, Dölken L, Jordan S, Podlech J, Ruzsics Z, Jauch KW, Reddehase MJ, Koszinowski UH (2011) Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog 7:e1002366PubMedCrossRef
28.
go back to reference *Kern M, Popov A, Scholz K, Schumak B, Djandji D, Limmer A, Eggle D, Sacher T, Zawatzky R, Holtappels R, Reddehase MJ, Hartmann G, Debey-Pascher S, Diehl L, Kalinke U, Koszinowski U, Schultze J, Knolle PA (2010) Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 138:336–346PubMedCrossRef *Kern M, Popov A, Scholz K, Schumak B, Djandji D, Limmer A, Eggle D, Sacher T, Zawatzky R, Holtappels R, Reddehase MJ, Hartmann G, Debey-Pascher S, Diehl L, Kalinke U, Koszinowski U, Schultze J, Knolle PA (2010) Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 138:336–346PubMedCrossRef
29.
go back to reference Stinski MF, Petrik DT (2008) Functional roles of the human cytomegalovirus essential IE86 protein. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 133–152 Stinski MF, Petrik DT (2008) Functional roles of the human cytomegalovirus essential IE86 protein. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 133–152
30.
go back to reference Meier JL, Stinski MF (2013) Major immediate-early enhancers and its gene products. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 10. Caister Academic Press, Norfolk, UK (in press) Meier JL, Stinski MF (2013) Major immediate-early enhancers and its gene products. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 10. Caister Academic Press, Norfolk, UK (in press)
31.
go back to reference Mocarski ES Jr, Hahn G, Lofgren White K, Xu J, Slobedman B, Hertel L, Aguirre SA, Noda S (2006) Myeloid cell recruitment and function in pathogenesis and latency. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk (UK), pp 465–481 Mocarski ES Jr, Hahn G, Lofgren White K, Xu J, Slobedman B, Hertel L, Aguirre SA, Noda S (2006) Myeloid cell recruitment and function in pathogenesis and latency. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk (UK), pp 465–481
32.
go back to reference White KL, Slobedman B, Mocarski ES (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74:9333–9337PubMedCrossRef White KL, Slobedman B, Mocarski ES (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74:9333–9337PubMedCrossRef
33.
go back to reference Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987PubMed Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987PubMed
34.
go back to reference Meyers JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev Infect Dis 4:1119–1132PubMedCrossRef Meyers JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev Infect Dis 4:1119–1132PubMedCrossRef
35.
go back to reference Zaia JA (1993) Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 17:S392–S399PubMedCrossRef Zaia JA (1993) Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 17:S392–S399PubMedCrossRef
36.
go back to reference Riddell SR (1995) Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect 10:199–208PubMed Riddell SR (1995) Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect 10:199–208PubMed
37.
go back to reference Reddehase MJ, Weiland F, Münch K, Jonjic S, Lüske A, Koszinowski UH (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264–273PubMed Reddehase MJ, Weiland F, Münch K, Jonjic S, Lüske A, Koszinowski UH (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264–273PubMed
38.
go back to reference Holtappels R, Podlech J, Geginat G, Steffens HP, Thomas D, Reddehase MJ (1998) Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 72:7201–7212PubMed Holtappels R, Podlech J, Geginat G, Steffens HP, Thomas D, Reddehase MJ (1998) Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 72:7201–7212PubMed
39.
go back to reference *Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507PubMedCrossRef *Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507PubMedCrossRef
40.
go back to reference Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM (2006) Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 34:842–849PubMedCrossRef Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM (2006) Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 34:842–849PubMedCrossRef
41.
go back to reference *Grzimek NKA, Dreis D, Schmalz S, Reddehase MJ (2001) Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol 75:2692–2705PubMedCrossRef *Grzimek NKA, Dreis D, Schmalz S, Reddehase MJ (2001) Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol 75:2692–2705PubMedCrossRef
42.
go back to reference *Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK (2005) Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 79:326–340PubMedCrossRef *Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK (2005) Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 79:326–340PubMedCrossRef
43.
go back to reference *Simon CO, Holtappels R, Tervo HM, Böhm V, Däubner T, Oehrlein-Karpi SA, Kühnapfel B, Renzaho A, Strand D, Podlech J, Reddehase MJ, Grzimek NK (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456PubMedCrossRef *Simon CO, Holtappels R, Tervo HM, Böhm V, Däubner T, Oehrlein-Karpi SA, Kühnapfel B, Renzaho A, Strand D, Podlech J, Reddehase MJ, Grzimek NK (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456PubMedCrossRef
44.
go back to reference *Simon CO, Kühnapfel B, Reddehase MJ, Grzimek NKA (2007) Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription. J Virol 81:7805–7810PubMedCrossRef *Simon CO, Kühnapfel B, Reddehase MJ, Grzimek NKA (2007) Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription. J Virol 81:7805–7810PubMedCrossRef
45.
go back to reference *Simon CO, Seckert CK, Grzimek NKA, Reddehase MJ (2006) Murine model of cytomegalovirus latency and reactivation: the silencing/desilencing and immune sening hypothesis. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk (UK), pp 483–500 *Simon CO, Seckert CK, Grzimek NKA, Reddehase MJ (2006) Murine model of cytomegalovirus latency and reactivation: the silencing/desilencing and immune sening hypothesis. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk (UK), pp 483–500
46.
go back to reference Boshart M, Weber F, Jahn G, Dorsch-Häsler K, Fleckenstein B, Schaffner W (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530PubMedCrossRef Boshart M, Weber F, Jahn G, Dorsch-Häsler K, Fleckenstein B, Schaffner W (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530PubMedCrossRef
47.
go back to reference Dorsch-Häsler K, Keil GM, Weber F, Jasin M, Schaffner W, Koszinowski UH (1985) A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci USA 82:8325–8329PubMedCrossRef Dorsch-Häsler K, Keil GM, Weber F, Jasin M, Schaffner W, Koszinowski UH (1985) A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci USA 82:8325–8329PubMedCrossRef
48.
go back to reference Stinski MF, Isomura H (2008) Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol 197:223–231PubMedCrossRef Stinski MF, Isomura H (2008) Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol 197:223–231PubMedCrossRef
49.
go back to reference Keil GM, Ebeling-Keil A, Koszinowski UH (1987) Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol 61:526–533PubMed Keil GM, Ebeling-Keil A, Koszinowski UH (1987) Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol 61:526–533PubMed
50.
go back to reference Keil GM, Ebeling-Keil A, Koszinowski UH (1987) Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J Virol 61:1901–1908PubMed Keil GM, Ebeling-Keil A, Koszinowski UH (1987) Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J Virol 61:1901–1908PubMed
51.
go back to reference Messerle M, Keil GM, Koszinowski UH (1991) Structure and expression of murine cytomegalovirus immediate-early gene 2. J Virol 65:1638–1643PubMed Messerle M, Keil GM, Koszinowski UH (1991) Structure and expression of murine cytomegalovirus immediate-early gene 2. J Virol 65:1638–1643PubMed
52.
go back to reference Messerle M, Bühler B, Keil GM, Koszinowski UH (1992) Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol 66:27–36PubMed Messerle M, Bühler B, Keil GM, Koszinowski UH (1992) Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol 66:27–36PubMed
53.
go back to reference Adachi N, Lieber MR (2002) Bidirectional gene organization: a common architectural feature of the human genome. Cell 109:807–809PubMedCrossRef Adachi N, Lieber MR (2002) Bidirectional gene organization: a common architectural feature of the human genome. Cell 109:807–809PubMedCrossRef
54.
go back to reference Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM (2004) An abundance of bidirectional promoters in the human genome. Genome Res 14:62–66PubMedCrossRef Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM (2004) An abundance of bidirectional promoters in the human genome. Genome Res 14:62–66PubMedCrossRef
55.
go back to reference Li YY, Yu H, Guo ZM, Guo TQ, Tu K, Li YX (2006) Systematic analysis of head-to-head gene organization: evolutionary conservation and potential biological relevance. PLoS Comput Biol 2:e74PubMedCrossRef Li YY, Yu H, Guo ZM, Guo TQ, Tu K, Li YX (2006) Systematic analysis of head-to-head gene organization: evolutionary conservation and potential biological relevance. PLoS Comput Biol 2:e74PubMedCrossRef
56.
go back to reference Redwood AJ, Shellam GR, Smith LM (2013) Molecular evolution of murine cytomegalovirus genomes. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 2. Caister Academic Press, Norfolk, UK (in press) Redwood AJ, Shellam GR, Smith LM (2013) Molecular evolution of murine cytomegalovirus genomes. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 2. Caister Academic Press, Norfolk, UK (in press)
57.
go back to reference Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M (2008) Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol 197:233–240PubMedCrossRef Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M (2008) Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol 197:233–240PubMedCrossRef
58.
go back to reference Angulo A, Ghazal P, Messerle M (2000) The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol 74:11129–11136PubMedCrossRef Angulo A, Ghazal P, Messerle M (2000) The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol 74:11129–11136PubMedCrossRef
59.
go back to reference Gribaudo G, Riera L, Lembo D, De Andrea M, Gariglio M, Rudge TL, Johnson LF, Landolfo S (2000) Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol 74:4979–4987PubMedCrossRef Gribaudo G, Riera L, Lembo D, De Andrea M, Gariglio M, Rudge TL, Johnson LF, Landolfo S (2000) Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol 74:4979–4987PubMedCrossRef
60.
go back to reference Lembo D, Gribaudo G, Hofer A, Riera L, Cornaglia M, Mondo A, Angeretti A, Gariglio M, Thelander L, Landolfo S (2000) Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent cells. J Virol 74:11557–11565PubMedCrossRef Lembo D, Gribaudo G, Hofer A, Riera L, Cornaglia M, Mondo A, Angeretti A, Gariglio M, Thelander L, Landolfo S (2000) Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent cells. J Virol 74:11557–11565PubMedCrossRef
61.
go back to reference *Wilhelmi V, Simon CO, Podlech J, Böhm V, Däubner T, Emde S, Strand D, Renzaho A, Lemmermann NAW, Seckert CK, Reddehase MJ, Grzimek NKA (2008) Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues. J Virol 82:9900–9916PubMedCrossRef *Wilhelmi V, Simon CO, Podlech J, Böhm V, Däubner T, Emde S, Strand D, Renzaho A, Lemmermann NAW, Seckert CK, Reddehase MJ, Grzimek NKA (2008) Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues. J Virol 82:9900–9916PubMedCrossRef
62.
go back to reference Maul GG (2008) Initiation of cytomegalovirus infection at ND10. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 117–132 Maul GG (2008) Initiation of cytomegalovirus infection at ND10. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, pp 117–132
63.
go back to reference Ghazal P, Visser AE, Gustems M, Garcia R, Borst EM, Sullivan K, Messerle M, Angulo A (2005) Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J Virol 79:7182–7194PubMedCrossRef Ghazal P, Visser AE, Gustems M, Garcia R, Borst EM, Sullivan K, Messerle M, Angulo A (2005) Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J Virol 79:7182–7194PubMedCrossRef
64.
go back to reference *Rodríguez-Martín S, Kropp K, Wilhelmi V, Juranic Lisnic V, Yuan Hsieh W, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Jonjic S, Angulo A, Reddehase MJ, Ghazal P (2012) Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog 8:e1002901 *Rodríguez-Martín S, Kropp K, Wilhelmi V, Juranic Lisnic V, Yuan Hsieh W, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Jonjic S, Angulo A, Reddehase MJ, Ghazal P (2012) Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog 8:e1002901
65.
go back to reference Cardin RD, Abenes GB, Stoddart CA, Mocarski ES (1995) Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236–241PubMedCrossRef Cardin RD, Abenes GB, Stoddart CA, Mocarski ES (1995) Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236–241PubMedCrossRef
66.
go back to reference Chatellard P, Pankiewicz R, Meier E, Durrer L, Sauvage C, Imhof MO (2007) The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells. Biotechnol Bioeng 96:106–117PubMedCrossRef Chatellard P, Pankiewicz R, Meier E, Durrer L, Sauvage C, Imhof MO (2007) The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells. Biotechnol Bioeng 96:106–117PubMedCrossRef
67.
go back to reference *Kropp KA, Simon CO, Fink A, Renzaho A, Kühnapfel B, Podlech J, Reddehase MJ, Grzimek NKA (2009) Synergism between the components of the bipartite major immediate-early transcriptional enhancer of murine cytomegalovirus does not accelerate virus replication in cell culture and host tissues. J Gen Virol 90:2395–2401PubMedCrossRef *Kropp KA, Simon CO, Fink A, Renzaho A, Kühnapfel B, Podlech J, Reddehase MJ, Grzimek NKA (2009) Synergism between the components of the bipartite major immediate-early transcriptional enhancer of murine cytomegalovirus does not accelerate virus replication in cell culture and host tissues. J Gen Virol 90:2395–2401PubMedCrossRef
68.
go back to reference Angulo A, Messerle M, Koszinowski UH, Ghazal P (1998) Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol 72:8502–8509PubMed Angulo A, Messerle M, Koszinowski UH, Ghazal P (1998) Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol 72:8502–8509PubMed
69.
go back to reference Ghazal P, Messerle M, Osborn K, Angulo A (2003) An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol 77:3217–3322PubMedCrossRef Ghazal P, Messerle M, Osborn K, Angulo A (2003) An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol 77:3217–3322PubMedCrossRef
70.
go back to reference *Podlech J, Pintea R, Kropp KA, Fink A, Lemmermann NAW, Erlach KC, Isern E, Angulo A, Ghazal P, Reddehase MJ (2010) Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severe immunodeficient host tissues but fails in exponential growth. J Virol 84:6254–6261PubMedCrossRef *Podlech J, Pintea R, Kropp KA, Fink A, Lemmermann NAW, Erlach KC, Isern E, Angulo A, Ghazal P, Reddehase MJ (2010) Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severe immunodeficient host tissues but fails in exponential growth. J Virol 84:6254–6261PubMedCrossRef
71.
go back to reference Wang D, Bodovitz S (2010) Single cell analysis: the new frontier in “Omics”. Trends Biotechnol 28:281–290PubMedCrossRef Wang D, Bodovitz S (2010) Single cell analysis: the new frontier in “Omics”. Trends Biotechnol 28:281–290PubMedCrossRef
72.
go back to reference Toriello NM, Douglas ES, Thaitrong N, Hsiao SC, Francis MB, Bertozzi CR, Mathies RA (2008) Integrated microfluidic bioprocessor for single-cell gene expression analysis. Proc Natl Acad Sci USA 105:20173–20178PubMedCrossRef Toriello NM, Douglas ES, Thaitrong N, Hsiao SC, Francis MB, Bertozzi CR, Mathies RA (2008) Integrated microfluidic bioprocessor for single-cell gene expression analysis. Proc Natl Acad Sci USA 105:20173–20178PubMedCrossRef
73.
go back to reference *Lemmermann NA, Podlech J, Seckert CK, Kropp KA, Grzimek NK, Reddehase MJ, Holtappels R (2010) CD8 T-cell immunotherapy of cytomegalovirus disease in the murine model. In: Kabelitz D, Kaufmann SHE (eds) Methods in microbiology: immunology of infection. Academic Press, London, pp 369–420CrossRef *Lemmermann NA, Podlech J, Seckert CK, Kropp KA, Grzimek NK, Reddehase MJ, Holtappels R (2010) CD8 T-cell immunotherapy of cytomegalovirus disease in the murine model. In: Kabelitz D, Kaufmann SHE (eds) Methods in microbiology: immunology of infection. Academic Press, London, pp 369–420CrossRef
74.
go back to reference Steffens HP, Kurz S, Holtappels R, Reddehase MJ (1998) Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol 72:1797–1804PubMed Steffens HP, Kurz S, Holtappels R, Reddehase MJ (1998) Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol 72:1797–1804PubMed
75.
go back to reference *Böhm V, Seckert CK, Simon CO, Thomas D, Renzaho A, Gendig D, Holtappels R, Reddehase MJ (2009) Immune evasion proteins enhance cytomegalovirus latency in the lungs. J Virol 83:10293–10298PubMedCrossRef *Böhm V, Seckert CK, Simon CO, Thomas D, Renzaho A, Gendig D, Holtappels R, Reddehase MJ (2009) Immune evasion proteins enhance cytomegalovirus latency in the lungs. J Virol 83:10293–10298PubMedCrossRef
76.
go back to reference Thomas M, Reuter N, Stamminger T (2013) Multifaceted regulation of human cytomegalovirus gene expression. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 11. Caister Academic Press, Norfolk, UK, (in press) Thomas M, Reuter N, Stamminger T (2013) Multifaceted regulation of human cytomegalovirus gene expression. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol I, chap 11. Caister Academic Press, Norfolk, UK, (in press)
77.
go back to reference Hummel M, Zhang Z, Yan S, DePlaen I, Golia P, Varghese T, Thomas G, Abecassis MI (2001) Allogeneic transplantation induces expression of cytomegalovirus immediate-early gene in vivo: a model for reactivation from latency. J Virol 75:4814–4822PubMedCrossRef Hummel M, Zhang Z, Yan S, DePlaen I, Golia P, Varghese T, Thomas G, Abecassis MI (2001) Allogeneic transplantation induces expression of cytomegalovirus immediate-early gene in vivo: a model for reactivation from latency. J Virol 75:4814–4822PubMedCrossRef
78.
go back to reference Cook CH, Zhang Y, McGuinness BJ, Lahm MC, Sedmak DD, Ferguson RM (2002) Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 185:1395–1400PubMedCrossRef Cook CH, Zhang Y, McGuinness BJ, Lahm MC, Sedmak DD, Ferguson RM (2002) Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 185:1395–1400PubMedCrossRef
79.
go back to reference Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD (2006) Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 80:9151–9158PubMedCrossRef Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD (2006) Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 80:9151–9158PubMedCrossRef
80.
go back to reference Kurz SK, Reddehase MJ (1999) Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol 73:8612–8622PubMed Kurz SK, Reddehase MJ (1999) Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol 73:8612–8622PubMed
81.
go back to reference Reddehase MJ, Rothbard JB, Koszinowski UH (1989) A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651–653PubMedCrossRef Reddehase MJ, Rothbard JB, Koszinowski UH (1989) A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651–653PubMedCrossRef
82.
go back to reference *Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2:831–844PubMedCrossRef *Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2:831–844PubMedCrossRef
83.
go back to reference Reddehase MJ, Koszinowski UH (1984) Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312:369–371PubMedCrossRef Reddehase MJ, Koszinowski UH (1984) Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312:369–371PubMedCrossRef
84.
go back to reference *Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123/pp 89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495–11503PubMedCrossRef *Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123/pp 89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495–11503PubMedCrossRef
85.
go back to reference *Holtappels R, Thomas D, Podlech J, Reddehase MJ (2002) Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J Virol 76:151–160PubMedCrossRef *Holtappels R, Thomas D, Podlech J, Reddehase MJ (2002) Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J Virol 76:151–160PubMedCrossRef
86.
go back to reference Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450–458PubMed Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450–458PubMed
87.
go back to reference *Lemmermann NA, Kropp KA, Seckert CK, Grzimek NK, Reddehase MJ (2011) Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion. J Biomed Biotechnol 2011:812742PubMed *Lemmermann NA, Kropp KA, Seckert CK, Grzimek NK, Reddehase MJ (2011) Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion. J Biomed Biotechnol 2011:812742PubMed
88.
go back to reference Torti N, Walton SM, Murphy KM, Oxenius A (2011) Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol 41:2612–2618PubMedCrossRef Torti N, Walton SM, Murphy KM, Oxenius A (2011) Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol 41:2612–2618PubMedCrossRef
89.
go back to reference Torti N, Walton SM, Brocker T, Rülicke T, Oxenius A (2011) Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 7:e1002313PubMedCrossRef Torti N, Walton SM, Brocker T, Rülicke T, Oxenius A (2011) Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 7:e1002313PubMedCrossRef
90.
go back to reference *Seckert CK, Schader SI, Ebert S, Thomas D, Freitag K, Renzaho A, Podlech J, Reddehase MJ, Holtappels R (2011) Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J Gen Virol 92:1994–2005PubMedCrossRef *Seckert CK, Schader SI, Ebert S, Thomas D, Freitag K, Renzaho A, Podlech J, Reddehase MJ, Holtappels R (2011) Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J Gen Virol 92:1994–2005PubMedCrossRef
91.
go back to reference Karrer U, Wagner M, Sierro S, Oxenius A, Hengel H, Dumrese T, Freigang S, Koszinowski UH, Phillips RE, Klenerman P (2004) Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol 78:2255–2264PubMedCrossRef Karrer U, Wagner M, Sierro S, Oxenius A, Hengel H, Dumrese T, Freigang S, Koszinowski UH, Phillips RE, Klenerman P (2004) Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol 78:2255–2264PubMedCrossRef
92.
go back to reference Jarvis MA, Hansen SG, Nelson JA, Picker LJ, Früh K (2013) Vaccine vectors using the unique biology and immunology of cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 21. Caister Academic Press, Norfolk, UK (in press) Jarvis MA, Hansen SG, Nelson JA, Picker LJ, Früh K (2013) Vaccine vectors using the unique biology and immunology of cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, vol II, chap 21. Caister Academic Press, Norfolk, UK (in press)
Metadata
Title
Viral latency drives ‘memory inflation’: a unifying hypothesis linking two hallmarks of cytomegalovirus infection
Authors
Christof K. Seckert
Marion Grießl
Julia K. Büttner
Sabine Scheller
Christian O. Simon
Kai A. Kropp
Angélique Renzaho
Birgit Kühnapfel
Natascha K. A. Grzimek
Matthias J. Reddehase
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 4/2012
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-012-0273-y

Other articles of this Issue 4/2012

Medical Microbiology and Immunology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine